Business Description
Sofwave Medical Ltd
ISIN : IL0011754392
Total Employee Number:
151Description
Sofwave Medical Ltd is engaged in the development, production, marketing, and sale of systems for skin rejuvenation and firming treatments. SUPERB, Synchronous Ultrasound Parallel Beam technology, is the company's FDA-cleared technology to improve facial lines and wrinkles, lift the eyebrows and lax submental tissue (beneath the chin), lift lax skin in the arms, and provide short-term improvement in the appearance of cellulite and treatment of acne scars. Its Pure Impact module uses EMS technology and is cleared for muscle toning. Sofwave's products provide physicians with effective and safe aesthetic solutions for their patients. Geographically, it generates maximum revenue from the United States, followed by East Asia, Europe and the Middle East, and other regions.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 24.29 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 0.14 | |||||
Interest Coverage | 47.69 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 12.6 | |||||
Beneish M-Score | -2.8 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 28.2 | |||||
3-Year Book Growth Rate | -1.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 23.96 | |||||
9-Day RSI | 32.15 | |||||
14-Day RSI | 32.78 | |||||
3-1 Month Momentum % | -29.42 | |||||
6-1 Month Momentum % | 5.23 | |||||
12-1 Month Momentum % | 60.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.43 | |||||
Quick Ratio | 2.18 | |||||
Cash Ratio | 1.6 | |||||
Days Inventory | 85.57 | |||||
Days Sales Outstanding | 30.39 | |||||
Days Payable | 117.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.7 | |||||
Shareholder Yield % | -0.21 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 75.01 | |||||
Operating Margin % | 9.91 | |||||
Net Margin % | 8.24 | |||||
EBITDA Margin % | 11 | |||||
FCF Margin % | 13.83 | |||||
OCF Margin % | 14.57 | |||||
ROE % | 26.82 | |||||
ROA % | 15.89 | |||||
ROIC % | 146.21 | |||||
3-Year ROIIC % | 2362.47 | |||||
ROC (Joel Greenblatt) % | 205.47 | |||||
ROCE % | 28.29 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 60.76 | |||||
PE Ratio without NRI | 60.76 | |||||
Price-to-Owner-Earnings | 35.76 | |||||
PS Ratio | 4.86 | |||||
PB Ratio | 11.92 | |||||
Price-to-Tangible-Book | 11.87 | |||||
Price-to-Free-Cash-Flow | 35.11 | |||||
Price-to-Operating-Cash-Flow | 33.31 | |||||
EV-to-EBIT | 45.13 | |||||
EV-to-EBITDA | 36.83 | |||||
EV-to-Revenue | 4.05 | |||||
EV-to-FCF | 29.29 | |||||
Price-to-GF-Value | 1.16 | |||||
Price-to-Graham-Number | 5.67 | |||||
| Price-to-Net-Current-Asset-Value | 14.01 | |||||
| Price-to-Net-Cash | 35.24 | |||||
Earnings Yield (Greenblatt) % | 2.22 | |||||
FCF Yield % | 3.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SOFWF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sofwave Medical Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 95.374 | ||
| EPS (TTM) ($) | 0.19 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 71.79 | ||
| 14-Day RSI | 32.78 | ||
| 14-Day ATR ($) | 0.227842 | ||
| 20-Day SMA ($) | 12.002 | ||
| 12-1 Month Momentum % | 60.42 | ||
| 52-Week Range ($) | 7 - 16.25 | ||
| Shares Outstanding (Mil) | 36.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sofwave Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sofwave Medical Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sofwave Medical Ltd Frequently Asked Questions
What is Sofwave Medical Ltd(SOFWF)'s stock price today?
The current price of SOFWF is $11.63. The 52 week high of SOFWF is $16.25 and 52 week low is $7.00.
When is next earnings date of Sofwave Medical Ltd(SOFWF)?
The next earnings date of Sofwave Medical Ltd(SOFWF) is .
Does Sofwave Medical Ltd(SOFWF) pay dividends? If so, how much?
Sofwave Medical Ltd(SOFWF) does not pay dividend.
Press Release
Articles on Sofwave Medical Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers